Speakers

Albert Ribickas

Associate Director, Operations, Cell Therapy Facility

Moffitt Cancer Center

Ali Mohamed

SVP of CMC

Immatics

Amish Patel

VP of Technical Operations

Calidi Biotherapeutics

Amnon Eylath

VP, Head of Quality

Minovia Therapeutics

Barbra Sasu

Chief Scientific Officer

Allogene Therapeutics

Beatriz Aranda

Team Leader

Cellectis

Bertie MacArthur

Account Manager

Beacon Targeted Therapies

Blake Aftab

CSO

Adicet Bio Inc.

Cedric Cleyrat

Scientific Director Cell Therapy Engineering Strategy & Innovation

Bristol Myers Squibb

Charles Mooney

VP

OBI - Biosharing Network

Charles Nicolette

Preseident & Chief Executive Officer

CoImmune

Cokey Nguyen

Chief Scientific Officer

Atara Biotherapeutics

Derek Tan

Member, Tri-institutional Professor, Chair, Chemical Biology Program

Memorial Sloan Kettering Cancer Center

Ebba Sohlberg

Project Manager

Karolinska Institutet

Elisa Gambini

Chief Technology & Operating Officer

Oloker Therapeutics

Elizabeth Garner

Associate Director - T Cell Therapeutics

Caribou Biosciences

Eric Strati

CEO

Gift of Life Biologics

Evren Alici

Associate Professor, Co-director

NextGenNK competence Center, Karolinska Institutet

Greg Kunst

President, CEO

Aurion Biotech

Guanghui Hu

Chief Executive Officer

Naki Therapeutics

Guillaume Carmona

Senior Director, Product Development

Avenge Bio

Hina Chaudhry

Professor of Medicine

Icahn School of Medicine at Mount Sinai

James McDowell

HRI Scientist

Roswell Park Comprehensive Cancer Center

Jason Acker

Associate Vice-President & Professor - Research Integrity Support

University of Alberta

Jeff Liter

Chief Executive Officer

Luminary Therapeutics

Jennifer Chain

Scientific Director - Research & Development

OBI, Biosharing Network

Jim Green

Senior Director Engineering and Automation

Bayer

Joseph Gold

Vice President - Technical Operations

Catamaran Bio

Joy Aho

Director of Product Management

Be The Match BioTherapies

Kari Winning

Senior Director, Business Development

American Red Cross Cell & Gene Therapy Solutions

Kate Rochlin

Chief Operating Officer

IN8Bio

Lauren Greene

Vice President of Donor Operations

Discovery Life Sciences

Luis Borges

CSO

Century Tx

Luke Pase

Chief Technology Officer

Anocca

Marco Alessandrini

Chief Technical Officer

Antion Bio

Mark Frattini

Chief Medical Officer

Cellectis

Michael Baker

CEO

Arovella Therapeutics

Monika Maleszewska

Associate Director, Cell Therapy Products

CareDx

Neil Blackburn

Senior Director Process and Analytical Development

Omnia Bio Inc

Noelle Hutchins

Investment Associate

Omega Funds

Oscar Segurado

CMO

ASC Therapeutics

Rick Morgan

Chief Scientific Officer

Be Biopharma

Ruchi Sharma

Staff Scientist

National Eye Institute

Rui Tostoes

Vice President - Chemistry Manufacturing & Control

ImmuneBridge

Sai-Wen Tang

R&D Director

Acepodia

Samuel Zhang

Chief Business Officer

Gracell Biotechnologies

Stephen Chen

Chief Technology Officer

Tevogen Bio

Sumona Sarkar

Biomedical Engineer

National Institute of Standards & Technology - NIST

Tim Gallagher

CBO

PhosphoGam

Tirtha Charkrabortya

CSO

VOR Biopharma
New for 2023!

Tomoki Otani

Director, BD

Logomix

Tracey Turner

Scientist, Formulation & Cryobiology in the Cell Therapy Development Organization

Bristol Myers Squibb
New for 2023!

Uday Kumar K

VP-Technical Operation

Stempeutics Research Pvt Ltd.
New for 2023!

Veronica Ricci

QA&RA

Oloker Therapeutics

William Van Der Touw

Senior Vice President - Translational & Discovery Research

Celularity Inc.

Yannick Bulliard

Senior Director - Research

Appia Bio

Yu Qian

Associate Director - Cell Therapies, Chemistry Manufacturing & Control

Takeda

2023 FULL EVENT GUIDE